- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 16:42 | LyondellBasell downgraded at BMO Capital on weakening prices | ||
| 16:42 | Guardian International Equity Select ETF declares CAD 0.0776 dividend | ||
| 16:42 | Goldman, T. Rowe Price launch model portfolios for wealthy clients | ||
| 16:36 | Guardian Canadian Diversified Core Equity Fund ETF declares CAD 0.1035 dividend | ||
| 16:36 | Airbus is said to have delivered 30 planes in first half of December | ||
| 16:36 | Guardian Ultra-Short US T-Bill Fund ETF Units declares CAD 0.1536 dividend | ||
| 16:36 | Guardian Ultra-Short Canadian T-Bill Fund ETF Units declares CAD 0.0928 dividend | ||
| 16:30 | Phillips 66 boosts 2026 capex plan to $2.4B | ||
| 16:18 | Nvidia rolls out Nemotron 3 open models for building agentic AI applications | ||
| 16:18 | Sanofi in deal worth up to $1.7B with Dren Bio for autoimmune disease treatments | ||
| 16:12 | Fed's Miran backs quicker rate-easing pace to get closer to neutral rate | ||
| 16:12 | Benchmark bullish on Gloo, initiates coverage at Buy with $14 target | ||
| 16:12 | Lucid launches 'Lucid Recharged' program to sell certified, pre-owned EVs | ||
| 16:06 | Homebuilder sentiment inches up in December | ||
| 16:06 | Dollar edges lower at the start of a busy week: Currency Recap | ||
| 16:06 | Guardian Investment Grade Corporate Bond ETF declares CAD 0.169 dividend | ||
| 16:06 | Here are the major earnings after the close Monday | ||
| 16:06 | Guardian i3 Global Dividend Premium Yield Fund declares CAD 0.0833 dividend | ||
| 16:00 | Guardian Directed Premium Yield Portfolio declares CAD 0.1164 dividend | ||
| 16:00 | Potash market shows muted reaction to lifting of Belarus sanctions | ||
| 16:00 | Guardian Directed Premium Yield Portfolio Hedge ETF Units declares CAD 0.1231 dividend | ||
| 15:54 | Guardian Directed Equity Path Portfolio ETF Units declares CAD 0.0673 dividend | ||
| 15:48 | Guardian Directed Equity Path Portfolio Hedge ETF Units declares CAD 0.0671 dividend | ||
| 15:48 | Gilead Yeztugo HIV combo pill meets goal in second phase 3 trial | ||
| 15:48 | Gevo names Bloom as CEO, succeeding Gruber upon April retirement |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .